title: Crucial Role of Viral Reactivation in the Development of Severe Drug Eruptions: a Comprehensive Review.
abstract: A growing number of cells, mediators, and pathways have been implicated in severe drug eruptions. Fifteen years ago, we published landmark studies that sparked the current advances in our understanding of the role of viral reactivations in severe drug eruptions. Viral reactivations then became critically important as diagnostic tools, but how precisely they participated in the pathogenesis remained less well-defined. The question of whether viral reactivations are pathogenic or are instead as epiphenomenon of severe tissue damage has plagued the field of drug allergy for some decades. Recent evidence points to a crucial role for tissue-resident memory T (TRM) cells in immune protection against viral infections. Yet immune protection against viral infections is but one side of a coin, the other side of which comprises effector cells capable of mediating severe immunopathology: Once drug antigen is cross-recognized by these T cells, they could be activated to kill surrounding epidermal cells, resulting in drug-induced tissue damage. Such TRM cells could persistently reside in the skin lesions of fixed drug eruptions (FDE) and are most likely a major cell type responsible for the development of FDE. We also discuss the role of regulatory T (Treg) cells in the setting of drug allergy, in which herpesviruses are reactivated in sequence. Although many details of the complicated interactions among viruses, anti-viral immune responses, TRM cells, and Treg cells remain to be elucidated, we review the current status of this rapidly advancing field.
authors.affiliation: Department of Dermatology, School of Medicine, Kyorin University, Mitaka, Tokyo, 181-8611, Japan.|Division of Flow Cytometry, School of Medicine, Kyorin University, Mitaka, Tokyo, 181-8611, Japan.
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Shiohara
authors.affiliation: Department of Dermatology, School of Medicine, Kyorin University, Mitaka, Tokyo, 181-8611, Japan.
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Ushigome
authors.affiliation: Department of Dermatology, School of Medicine, Kyorin University, Mitaka, Tokyo, 181-8611, Japan.
authors.forename: Yoko
authors.initials: Y
authors.lastname: Kano
authors.affiliation: Division of Flow Cytometry, School of Medicine, Kyorin University, Mitaka, Tokyo, 181-8611, Japan. ryo@ks.kyorin-u.ac.jp.
authors.forename: Ryo
authors.initials: R
authors.lastname: Takahashi
mesh_terms: D000818:Animals; D003429:Cross Reactions; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D003875:Drug Eruptions / Q000175:diagnosis / Q000276:immunology / Q000821:virology*; D006564:Herpesviridae / Q000276:immunology*; D006801:Humans; D007156:Immunologic Memory; D012867:Skin / Q000187:drug effects / Q000276:immunology* / Q000821:virology; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000276:immunology* / Q000821:virology; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology* / Q000821:virology; D014775:Virus Activation; D014777:Virus Diseases / Q000276:immunology*
keywords: Drug-induced hypersensitivity syndrome; Fixed drug eruption; Graft-versus-host disease; Herpesviruses; Immune reconstitution syndrome; Regulatory T cells; Resident memory T cells
references.citation: J Exp Med. 1995 Dec 1;182(6):1703-15
references.pmid: 7500015
references.citation: Br J Dermatol. 2007 Nov;157(5):934-40
references.pmid: 17854362
references.citation: Clin Infect Dis. 2007 Dec 1;45(11):1470-5
references.pmid: 17990230
references.citation: Autoimmun Rev. 2009 May;8(6):488-94
references.pmid: 19239928
references.citation: Chem Immunol Allergy. 2012;97:106-21
references.pmid: 22613857
references.citation: Arch Dermatol. 2009 Sep;145(9):1030-6
references.pmid: 19770444
references.citation: Nature. 2012 Feb 29;483(7388):227-31
references.pmid: 22388819
references.citation: Proc Natl Acad Sci U S A. 2012 May 1;109(18):7037-42
references.pmid: 22509047
references.citation: Nat Immunol. 2009 May;10(5):524-30
references.pmid: 19305395
references.citation: Clin Exp Dermatol. 1997 May;22(3):118-23
references.pmid: 9425690
references.citation: Curr HIV/AIDS Rep. 2009 Aug;6(3):162-71
references.pmid: 19589302
references.citation: J Exp Med. 1994 Apr 1;179(4):1155-61
references.pmid: 7511682
references.citation: Eur J Immunol. 1997 Jul;27(7):1726-36
references.pmid: 9247584
references.citation: Arch Dermatol. 1998 Sep;134(9):1113-7
references.pmid: 9762024
references.citation: Br J Dermatol. 2008 Jun;158(6):1230-8
references.pmid: 18363767
references.citation: Curr Opin Allergy Clin Immunol. 2009 Aug;9(4):316-21
references.pmid: 19474709
references.citation: Int J Tuberc Lung Dis. 2005 Sep;9(9):1057-8
references.pmid: 16158902
references.citation: Br J Dermatol. 2006 Aug;155(2):301-6
references.pmid: 16882166
references.citation: Science. 2003 Feb 14;299(5609):1033-6
references.pmid: 12532024
references.citation: Am J Pathol. 2002 Oct;161(4):1337-47
references.pmid: 12368207
references.citation: Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18460-5
references.pmid: 19015529
references.citation: J Clin Invest. 2006 May;116(5):1443-56
references.pmid: 16614754
references.citation: Med Hypotheses. 1984 Jul;14(3):293-6
references.pmid: 6472157
references.citation: Arch Dermatol. 1998 Sep;134(9):1108-12
references.pmid: 9762023
references.citation: J Am Acad Dermatol. 2013 May;68(5):721-8
references.pmid: 23182063
references.citation: J Immunol. 2008 Nov 15;181(10):7356-66
references.pmid: 18981159
references.citation: Allergol Int. 2010 Dec;59(4):333-43
references.pmid: 20962568
references.citation: Br J Dermatol. 2007 May;156(5):1083-4
references.pmid: 17381452
references.citation: Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19739-44
references.pmid: 23150545
references.citation: Clin Infect Dis. 2005 Mar 1;40(5):756-9
references.pmid: 15714425
references.citation: Dermatology. 2002;205(2):159-61
references.pmid: 12218232
references.citation: Clin Exp Immunol. 1996 May;104(2):343-50
references.pmid: 8625531
references.citation: J Immunol. 2006 Mar 1;176(5):2691-6
references.pmid: 16493023
references.citation: Br J Dermatol. 1988 Jun;118(6):849-51
references.pmid: 2969746
references.citation: N Engl J Med. 1993 Jul 15;329(3):203-4
references.pmid: 8390616
references.citation: Clin Exp Dermatol. 2010 Dec;35(8):863-8
references.pmid: 20456395
references.citation: J Exp Med. 2009 Jan 16;206(1):209-19
references.pmid: 19139173
references.citation: J Eur Acad Dermatol Venereol. 2002 Jul;16(4):414-6
references.pmid: 12224708
references.citation: Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16741-6
references.pmid: 21930933
references.citation: Allergy. 2014 Jun;69(6):798-805
references.pmid: 24749495
references.citation: Dermatology. 2009;218(3):275-7
references.pmid: 19088463
references.citation: Sci Transl Med. 2010 Aug 25;2(46):46ra62
references.pmid: 20739682
references.citation: Lancet. 1967 Dec 2;2(7527):1176-8
references.pmid: 4168380
references.citation: J Immunol. 2009 Jun 15;182(12):8071-9
references.pmid: 19494333
references.citation: Curr Opin Immunol. 2011 Oct;23(5):641-7
references.pmid: 21840184
references.citation: Clin Infect Dis. 2008 Mar 1;46(5):696-702
references.pmid: 18230039
references.citation: Science. 2005 Aug 26;309(5739):1380-4
references.pmid: 16123302
references.citation: N Engl J Med. 1993 Jun 10;328(23):1670-4
references.pmid: 8487826
references.citation: Clin Rev Allergy Immunol. 2007 Oct;33(1-2):124-33
references.pmid: 18094951
references.citation: Br J Dermatol. 2007 May;156(5):1061-3
references.pmid: 17381460
references.citation: J Exp Med. 2007 May 14;204(5):979-85
references.pmid: 17452519
references.citation: Cancer. 2007 Jul 1;110(1):112-20
references.pmid: 17525971
references.citation: Medicine (Baltimore). 2002 May;81(3):213-27
references.pmid: 11997718
references.citation: Nature. 2011 Aug 14;477(7363):216-9
references.pmid: 21841802